Tag: SNMMI 2024

molecular-partners-and-orano-med-share-positive-preclinical-data-of-their-dll3-targeting-radio-darpin-therapy-rdt-candidate-mp0712-at-snmmi-2024

Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy...

Exciting Preclinical Data Shared by Molecular Partners and Orano Med at SNMMI 2024June 11, 2024 01:00 ETMolecular Partners AG and Orano Med have unveiled...

BREAKING NEWS

Top News